Telehealth Advertising: What FDA, the FTC and the Ad Platforms Say About Compounded Drug Claims
Telehealth companies have become the main target of FDA's compounded GLP-1 marketing enforcement. The agency has published the claims it considers false or misleading, and the FTC has its own rules on reviews and health claims.
Key Highlights
- FDA's telehealth guidance lists claims it calls false or misleading: branding that implies the telehealth company is the compounder, calling a compounded drug generic or the same as an approved one, implying FDA approval, and calling a pharmacy FDA-approved.
- FDA announced 30 warning letters to telehealth companies on compounded GLP-1 claims on March 3, 2026, its second group since September 2025.
- The FTC's Consumer Reviews and Testimonials Rule, effective October 21, 2024, bans fake reviews and review suppression.
- Google and Meta gate some healthcare telehealth advertising behind LegitScript certification.
What FDA Says Is Misleading
FDA's telehealth guidance page on promoting compounded drugs lists claims it describes as false or misleading. They include branding or labeling that makes it look as if the telehealth company is the compounder, describing a compounded drug as generic or the same as an approved drug, implying FDA approval or evaluation, saying a compounded product is clinically proven to match the approved drug, and describing a pharmacy as FDA-approved or FDA-licensed.
The Warning Letters
On March 3, 2026 FDA announced warning letters to 30 telehealth companies about illegal marketing of compounded GLP-1 drugs, the second group since a crackdown that began in September 2025. A sample letter from June 2026 cites sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act for claims such as getting the same results as a brand-name drug and describing compounding pharmacies as FDA approved. Counts of letters beyond those FDA published vary by source.
The FTC
- term: text
- term: text
- term: text
Platforms and LegitScript
LegitScript's own telemedicine page says certification is required by many major credit cards and internet platforms, and covers advertising on Google, Microsoft, Meta and TikTok. Which of your ads need it depends on what you prescribe and how you take payment, and certification does not guarantee ad approval.
Writing Compliant Telehealth Copy
- term: text
- term: text
- term: text
- term: text
- term: text
Disclaimer
This article is general educational information, not legal advice. Telehealth rules differ by state and change often, so confirm specifics with health care regulatory counsel in each state where you treat patients.
MedGrid MSO provides management services to independently owned practices; it does not practise medicine and does not direct clinical decisions. Requirements vary by state and by service, and change over time — nothing on this page is legal or medical advice. Talk to us or your own counsel before making a structural decision for your clinic.